Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 17, 2019ToxicologyOpen Access

Anti-tumor properties of methoxylated analogues of resveratrol in malignant MCF-7 but not in non-tumorigenic MCF-10A mammary epithelial cell lines

View Full Paper
Ask AI
Bookmark
Share

Authors

ABA. BrandNational Institute for Public Health and the EnvironmentJVJudith VillevoyeUtrecht UniversitySNSandra M. NijmeijerUtrecht University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brand et al. (2019) studied this question.

synapsesocial.com/papers/6a908798ed78fcc1e60d3c2fhttps://doi.org/10.1016/j.tox.2019.04.009
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antiproliferative effect of synthetic resveratrol on human breast epithelial cells.1998 · 275 citations
  2. 2The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B12002 · 378 citations
  3. 3The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines2010 · 580 citations
  4. 4Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells2003 · 57 citations
  5. 5Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: An <i>in silico</i> and biochemical approach targeting integrin αvβ32011 · 69 citations